Clinical Trials Browser

Withdrawn × Delirium × Clear all

NCT06834386 2025-05-01

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Phase 4 Withdrawn

Delirium, Sleep Initiation and Maintenance Disorders

NCT03360474 2018-05-31

Implementation of a Delirium Screening

Phase NA Withdrawn

Delirium, Neoplasms

NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Phase 2 Withdrawn

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable